ArticleJournal of pharmacy & bioallied sciences2025
Correlation between Dengue Hemorrhagic Fever Severity and Comorbid Conditions in Patients.
Article in Journal of pharmacy & bioallied sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To evaluate the relationship between the degree of dengue hemorrhagic fever (DHF) and the presence of comorbidities among hospitalized patients in a tertiary care institute in India. Materials and Methods: This cross-sectional observational study included 350 serologically confirmed dengue adult inpatients. Patients were grouped by WHO-defined dengue fever (DHF Grades 1-3). Age, gender, dengue severity, and comorbidities like hypertension, diabetes, chronic obstructive pulmonary disease, chronic kidney disease, cardiovascular disease (CVD), human immunodeficiency virus, chronic liver disease (CLD), and stroke were recorded. Results: Among 350 patients, 56.6% were male and 88.9% were aged under 50 years. The most prevalent classification was DHF Grade 1 at 62.6%, followed by Grade 2 at 30.9% and Grade 3 at 2.9%. Strong correlations were identified between the severity of DHF and comorbidities such as hypertension, diabetes, CVD, and CLD ( Conclusion: High DHF grades are linked to comorbidities such as hypertension, diabetes, CVD, and CLD. In dengue-endemic areas, early identification and monitoring of high-risk patients can improve care and prevent catastrophic outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.